StreetInsider.com News Articles

Form S-8 Inogen Inc

Fri, 24 Jul 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260724/26814050.html

Form S-8 Inogen Inc

Fri, 24 Jul 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260724/26814050.html

Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026

Thu, 16 Jul 2026 08:30:00 -0400

BEVERLY, Mass.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2026 financial results after the market closes on Thursday, August 6, 2026. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET.

Individuals interested in listening to the conference call may do so by dialing:

U.S. domestic callers (877) 841-3961
Non-U.S. callers (201) 689-8589

Please reference Inogen to join the call. A

Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026

Thu, 16 Jul 2026 08:30:00 -0400

Individuals interested in listening to the conference call may do so by dialing:

U.S. domestic callers (877) 841-3961
Non-U.S. callers (201) 689-8589

Please reference Inogen to join the call. A

Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026

Thu, 16 Jul 2026 08:30:00 -0400

Individuals interested in listening to the conference call may do so by dialing:

U.S. domestic callers (877) 841-3961
Non-U.S. callers (201) 689-8589

Please reference Inogen to join the call. A

Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026

Thu, 16 Jul 2026 08:30:00 -0400

Individuals interested in listening to the conference call may do so by dialing:

U.S. domestic callers (877) 841-3961
Non-U.S. callers (201) 689-8589

Please reference Inogen to join the call. A

Form 4 Inogen Inc For: Jul 06 Filed by: Reding Andrew P.

Thu, 09 Jul 2026 09:05:00 -0400

si-local-file:///var/storage/secattach/20260709/26751110.html

Form 4 Inogen Inc For: Jul 06 Filed by: Reding Andrew P.

Thu, 09 Jul 2026 09:05:00 -0400

si-local-file:///var/storage/secattach/20260709/26751110.html

Form 3 Inogen Inc For: Jul 06 Filed by: Reding Andrew P.

Thu, 09 Jul 2026 09:03:00 -0400

si-local-file:///var/storage/secattach/20260709/26751091.html

Form 3 Inogen Inc For: Jul 06 Filed by: Reding Andrew P.

Thu, 09 Jul 2026 09:03:00 -0400

si-local-file:///var/storage/secattach/20260709/26751091.html

Form 4 Inogen Inc For: Jul 01 Filed by: Yi Boyer Jennifer M

Mon, 06 Jul 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260706/26736111.html

Form 4 Inogen Inc For: Jul 01 Filed by: Yi Boyer Jennifer M

Mon, 06 Jul 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260706/26736111.html

Form 144 Inogen Inc Filed by: Yi Boyer Jennifer M

Wed, 01 Jul 2026 16:50:00 -0400

si-local-file:///var/storage/secattach/20260701/26721666.html

Form 144 Inogen Inc Filed by: Yi Boyer Jennifer M

Wed, 01 Jul 2026 16:50:00 -0400

si-local-file:///var/storage/secattach/20260701/26721666.html

Form 8-K Inogen Inc For: Jul 01

Wed, 01 Jul 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260701/26720693.html

Form 8-K Inogen Inc For: Jul 01

Wed, 01 Jul 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260701/26720693.html

Inogen names Andy Reding as chief operating officer

Wed, 01 Jul 2026 16:05:28 -0400

Inogen, Inc. (Nasdaq: INGN) announced the appointment of Andy Reding to the newly created role of Chief Operating Officer, effective July 6, 2026, according to a company press release.

Reding brings more than 30 years of experience in medical technology, commercial operations, product development, and healthcare reimbursement. He most recently served as Chief Commercial Officer of Viant Medical, where he spent more than six years leading teams supporting medical-device design and manufacturing programs. Before that, he served as Vice President and General Manager of Hillrom Respiratory Health, overseeing sales, marketing, research and development, and reimbursement.